Profile: The Kilifi Health and Demographic Surveillance System (KHDSS)
Profile: The Kilifi Health and Demographic Surveillance System (KHDSS)
复制标题
DOI：
10.1093/ije/dys062
复制
发表时间：
2012-06-01
影响因子：
7.7
通讯作者：
Williams, Thomas N.
中科院分区：
文献类型：
--
作者：
Scott, J. Anthony G.;Bauni, Evasius;Williams, Thomas N.
位于肯尼亚印度洋沿岸的Kilifi卫生和人口监测系统于2000年建立，记录出生、怀孕、移徙事件和死亡情况，并通过4个月一次的家庭访问进行维护。选择研究区域是为了收集基利菲地区医院收治的大多数患者。KHDSS有260 000名居民，医院每年收治4400名儿科患者和3400名成人患者。在医院，通过计算机搜索人口登记册，发病率事件在真实的时间内联系起来。2008年，KHDSS疫苗诊所扩大了相关监测范围，KHDSS数据用于确定儿童传染病医院就诊的发生率（如轮状病毒腹泻、肺炎球菌病），以检测遗传风险因素之间的关联（如地中海贫血病和镰状细胞病）和传染病，以确定社区慢性病的流行率（如癫痫），评估获得卫生保健的机会，并计算主要公共卫生干预措施的运作效果（如G.结合流感嗜血杆菌B型疫苗）。通过积极的社区参与方案，与居民保持融洽关系。建立了一个协作参与系统，以分享关于存活率、发病率、社会经济状况和疫苗覆盖率的数据。
The Kilifi Health and Demographic Surveillance System (KHDSS), located on the Indian Ocean coast of Kenya, was established in 2000 as a record of births, pregnancies, migration events and deaths and is maintained by 4-monthly household visits. The study area was selected to capture the majority of patients admitted to Kilifi District Hospital. The KHDSS has 260 000 residents and the hospital admits 4400 paediatric patients and 3400 adult patients per year. At the hospital, morbidity events are linked in real time by a computer search of the population register. Linked surveillance was extended to KHDSS vaccine clinics in 2008.KHDSS data have been used to define the incidence of hospital presentation with childhood infectious diseases (e.g. rotavirus diarrhoea, pneumococcal disease), to test the association between genetic risk factors (e.g. thalassaemia and sickle cell disease) and infectious diseases, to define the community prevalence of chronic diseases (e.g. epilepsy), to evaluate access to health care and to calculate the operational effectiveness of major public health interventions (e. g. conjugate Haemophilus influenzae type b vaccine). Rapport with residents is maintained through an active programme of community engagement. A system of collaborative engagement exists for sharing data on survival, morbidity, socio-economic status and vaccine coverage.